Media Watch
Tag:
IN THE NEWS: Gauteng goes big with HIV tests
The Gauteng health department aims to test three million people for HIV and to put almost one million people on to treatment in the new financial year.IN THE NEWS: Parents’ anguish after surgery left boy with HIV
They have undergone several HIV tests, And every time, the test results came back negative. However, their nine-year-old son is on antiretroviral treatment, having tested positive when he was just seven months old.IN THE NEWS: New ARV deal in SA
Two more international pharmaceutical giants will compete for their share of the world's biggest antiretroviral (ARV) market.IN THE NEWS: Grants cut as health improves!
HIV-Positive people have to eat healthily. But many cannot afford to do this because they are unemployed.IN THE NEWS: Generics end drug monopoly in India
India's move to strip German drugmaker Bayer of its exclusive rights to a cancer drug has set a precedent that could extend to other treatments, including modern HIV-Aids drugs, in a major blow to global pharmaceutical firms, experts say.IN THE NEWS: Generic rivals depress Aspen
Competition from generic medicines is eating into Aspen's South African market share and has resulted in an 11 percent decline in revenue to R2.9 billion in the country.ANALYSIS: Bonitas bungles breast is best
A Bonitas sponsored article in last week’s Mail&Guardian appears to give a round-up of the pros and cons that dominate debates on infant-feeding in South Africa, following big changes in government policy last year (including the withdrawal of free infant formula). But on closer examination its engagement with the issue is superficial at best.ANALYSIS: Deal, or no deal?
This weekend saw the South African government and Swiss pharmaceutical giant Lonza in an on-again, off-again and then on-again agreement on the establishment of a South African-based drug plant that could lower the cost of ARVs.
On Friday (10 February 2012) it seemed that last year’s speculation around the establishment of a state-owned drug manufacturing company was set to become a reality after the Department of Science and Technology announced that plans to develop the manufacturing facility would go ahead.
However, the next day, The Saturday Star reported that the government’s announcement was premature after the foreign pharmaceutical company released a statement indicating that the process was still at a very early stage.
